Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs (English, HTML)
Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs: English HTML file. From Health Canada, updated Dec 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-12-24
As a regulator, Health Canada plays an important role in protecting the health and safety of Canadians. Health Canada is committed to being transparent and open about its activities and to making timely and useful information available about health products and health product submissions. Greater transparency and openness with Canadians strengthens the trust in our regulatory decisions, and ultimately supports Canadians in making better decisions about their health.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file